Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/fda-approves-nonsteroidal-treatment-for-duchenne-muscular-dystrophy-302096571.html
https://www.biospace.com/article/releases/italfarmaco-group-enters-into-an-agreement-with-luye-pharma-to-commercialize-alzheimer-s-disease-treatment-rivastigmine-multi-day-transdermal-patch-in-four-european-countries/
https://www.biospace.com/article/releases/italfarmaco-receives-fda-rare-pediatric-disease-designation-for-givinostat-in-duchenne-muscular-dystrophy-announces-completed-enrollment-in-epidys-phase-3-trial/